Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.520
+0.030 (1.20%)
At close: Apr 17, 2026, 4:00 PM EDT
2.530
+0.010 (0.40%)
After-hours: Apr 17, 2026, 7:34 PM EDT
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $11.06 million as of April 17, 2026. Its market cap has increased by 31.67% in one year.
Market Cap
11.06M
Enterprise Value
-5.66M
1-Year Change
31.67%
Ranking
Category
Stock Price
$2.52
Market Cap Chart
Since February 13, 2015, Kiora Pharmaceuticals's market cap has decreased from $38.90M to $11.06M, a decrease of -71.57%. That is a compound annual growth rate of -10.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 10.00M | 38.89% |
| Dec 31, 2025 | 7.20M | -27.27% |
| Dec 31, 2024 | 9.90M | 147.50% |
| Dec 29, 2023 | 4.00M | 2.56% |
| Dec 30, 2022 | 3.90M | -79.58% |
| Dec 31, 2021 | 19.10M | -16.23% |
| Dec 31, 2020 | 22.80M | -37.36% |
| Dec 31, 2019 | 36.40M | 80.20% |
| Dec 31, 2018 | 20.20M | 9.78% |
| Dec 29, 2017 | 18.40M | 17.95% |
| Dec 30, 2016 | 15.60M | -25.71% |
| Dec 31, 2015 | 21.00M | -46.02% |
| Feb 13, 2015 | 38.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 12.13M |
| Chemomab Therapeutics | 12.02M |
| GT Biopharma | 11.96M |
| CytoMed Therapeutics | 11.95M |
| Theriva Biologics | 11.80M |
| BioVie | 11.76M |
| Genprex | 11.76M |
| Quoin Pharmaceuticals | 11.65M |